Valvular Heart Disease and Risk Score Systems in Clinical Practice

Valvular Heart Disease and Risk Score Systems in Clinical Practice

October 13, 2016 at 8:22 AM 0 comments

*Ricardo Casalino,1,2,3 Leonardo Jorge Cordeiro de Paula,1,2 Eduardo Bello Martins,2 Flavio Tarasoutchi1,2 1. Diagnostic and Preventive Medicine, Hospital Israelita Albert Einstein, São Paulo, Brazil 2. Heart Institute, University of São Paulo Medical School, São Paulo, Brazil 3. Santa Marcelina Hospital, Santa Marcelina Faculty, São Paulo, Brazil *Correspondence to ricardocasalino@gmail.com Disclosure:Read More

Cardiac Arrest in Pregnancy: End-Tidal CO2 Monitoring Could Guide Management in the Prehospital Setting

Cardiac Arrest in Pregnancy: End-Tidal CO2 Monitoring Could Guide Management in the Prehospital Setting

October 13, 2016 at 8:21 AM 0 comments

*Steinar Einvik,1 Thomas Lafrenz,2 Stein-Vegar Johansen,Ingrid Marie Ringen,4 Per P. Bredmose5 1. Department of Emergency Medicine and Prehospital Services, St. Olavs Hospital, Trondheim University Hospital, Trondheim, Norway 2. Department of Anaesthesia and Intensive Care, St. Olavs Hospital, Trondheim University Hospital, Trondheim, Norway 3. Department of Cardiothoracic Anaesthesia, St. Olavs Hospital,Read More

Clinical Trials for the Diagnosis and Management of Stable Ischaemic Heart Disease: Context, Status, and Future Implications

Clinical Trials for the Diagnosis and Management of Stable Ischaemic Heart Disease: Context, Status, and Future Implications

October 13, 2016 at 8:20 AM 0 comments

*David Corcoran,1,2 Kenneth Mangion,1,2 †Colin Berry1,2 1. West of Scotland Heart and Lung Centre, Golden Jubilee National Hospital, Clydebank, UK 2. British Heart Foundation Glasgow Cardiovascular Research Centre, Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UK *Correspondence to dcorcoran@nhs.net †All authors contributed equally Disclosure: Prof Berry wasRead More

Big Data and Cardiology: Time for Mass Analytics?

Big Data and Cardiology: Time for Mass Analytics?

April 5, 2016 at 8:58 AM 0 comments

*Rahul Potluri,1 Ignat Drozdov,2 Paul Carter,3 Jaydeep Sarma4 1. ACALM Study Unit in collaboration with Aston Medical School, Aston University, Birmingham, UK 2. Bering Limited, London, UK 3. Royal Free London NHS Trust, London, UK 4. North West Heart Centre, University Hospital of South Manchester, Manchester, UK *Correspondence to rahulpotluri@outlook.comRead More

Management of Blood Pressure Control: At the Cutting Edge

Management of Blood Pressure Control: At the Cutting Edge

November 23, 2015 at 9:22 AM 0 comments

This satellite symposium took place on 29th August 2015  as a part of the European Society of Cardiology Congress 2015 in London, UK Chairperson: Bryan Williams,1 Gianfranco Parati2 Speakers: Thomas W. Weiss,3 Jean-Jacques Mourad,4 Massimo Volpe5 1. Institute of Cardiovascular Science, University College London, London, UK 2. St Luca Hospital, IstitutoRead More

When the Going Gets Tough, the Tough Get Going

When the Going Gets Tough, the Tough Get Going

November 23, 2015 at 9:16 AM 0 comments

This satellite symposium took place on 13th June 2015 as  part of the 25th European Meeting on Hypertension and  Cardiovascular Protection in Milan, Italy Chairperson: Massimo Volpe1 Speakers: Josep Redòn,2 Michel Burnier,3 Massimo Volpe1 1. University of Rome “La Sapienza”, Sant’Andrea Hospital, Rome, Italy 2. Hospital Clinico, University of Valencia,Read More

Treatment of Hypertension in New Frontiers

Treatment of Hypertension in New Frontiers

October 20, 2015 at 9:11 AM 0 comments

This symposium took place on 30th August 2015 as a part of the European Society of Cardiology (ESC) Congress in London, UK Co-Chairs: Bryan Williams,1 Gordon Thomas McInnes2 Speakers: Bryan Williams,1 Gordon Thomas McInnes,2 Jesús Isea-Pérez,3 Jorge Sison4 1. University College London (UCL), London, UK 2. Institute of Cardiovascular andRead More

New Paradigms in Heart Failure: RAAS Inhibition and the Management of Hyperkalaemia

New Paradigms in Heart Failure: RAAS Inhibition and the Management of Hyperkalaemia

October 20, 2015 at 9:08 AM 0 comments

This symposium took place on 29th August 2015 as a part of the European Society of Cardiology Congress in London, UK Chair: John McMurray1 Speakers: Faiez Zannad,2 Ileana L. Piña,3 John McMurray1 1. University of Glasgow, Glasgow, UK 2. Henri Poincaré University of Nancy, Nancy, France 3. Montefiore-Einstein Medical Centre,Read More

International, Large-Scale, Real-World Clinical Data Confirm the Safety Profile of Rivaroxaban

International, Large-Scale, Real-World Clinical Data Confirm the Safety Profile of Rivaroxaban

October 20, 2015 at 9:07 AM 0 comments

*John Camm Division of Clinical Sciences, St George’s Hospital, University of London, London, UK *Correspondence to jcamm@sgul.ac.uk Disclosure: John Camm is a consultant to Bayer, Boehringer Ingelheim, Pfizer, BMS, and Daiichi Sankyo. Support: The publication of this article was funded by Bayer Pharmaceuticals. The views and opinions expressed are thoseRead More

Real-World Registry Study Confirms Fondaparinux Over Low-Molecular-Weight Heparin for NSTEMI

Real-World Registry Study Confirms Fondaparinux Over Low-Molecular-Weight Heparin for NSTEMI

October 20, 2015 at 9:07 AM 0 comments

*Tomas Jernberg, Karolina Szummer Department of Cardiology, Karolinska University Hospital, Stockholm, Sweden *Correspondence to tomas.jernberg@karolinska.se Disclosure: Tomas Jernberg and Karolina Szummer have both received honoraria for lectures from Aspen. Karolina Szummer has also received honoraria for lectures from AstraZeneca. Support: The publication of this article was funded by Aspen. TheRead More